Sarah Waliany: Reviewing the TRUST-1 trial investigating taletrectinib

Sarah Waliany, Thoracic Oncology Fellow at Mass General Cancer Center, shared the following post by Stephen V Liu, on X:

“Thank you Stephen V Liu! Enjoyed working with Jessica J Lin on reviewing the TRUST-1 trial investigating taletrectinib and the evolving landscape of therapies for ROS1+ NSCLC. So important that we continue to develop effective and tolerable therapies for these patients. ”

Quoting Stephen V Liu‘s post:

“Love the figures from the recent ROS1 editorial in Journal of Clinical Oncology from Drs. Sarah Waliany and Jessica J Lin as they provide perspective on the TRUST trial and talectrectinib for ROS1+ NSCLC.”

Source: Sarah Waliany/X and Stephen V Liu/X